info@gliapharm.com | +41 22 545 11 15
Partners and Collaborations
TRB Chemedica International
Partner Image

Research Collaboration with TRB Chemedica International: In vitro study of the metabolic effect of GM1 on brain cells
Innosuisse
Partner Image

Innosuisse, formerly Commission for Technology and Innovation (CTI) has supported GliaPharm's creation and early development through two research grants to Prof. Magistretti's laboratory at EPFL (2014-2017). Since 2016, Innosuisse has been supporting GliaPharm with its startup coaching program.
Fondation Campus Biotech Geneva
Partner Image

The Fondation Campus Biotech Geneva has hosted GliaPharm's headquarter and laboratory since 2017.

Fondation Rita Puccini pour l'étude de la sclérose latérale amyotrophique

The Fondation Rita Puccini pour l'étude de la sclérose latérale amyotrophique has been supporting research at GliaPharm to identify and develop new drugs for the treatment of ALS (2016-2019).
EPFL
Partner Image

GliaPharm is a spin-off from Prof. Pierre Magistretti’s laboratory at Ecole Polytechnique Fédérale de Lausanne (EPFL). In addition, EPFL has financially participated in GliaPharm early lead optimization, in particular through financial support from technology transfer office (TTO)'s Enable grant (2016).